Green Cross Corp.

Green Cross Corp.

Green Cross Corp.

Overview
Date Founded

1969

Headquarters

107 Ihyeon-ro 30beon-gil,Giheung-gu,Yongin, Gyeonggi 16924

Type of Company

Public

Employees (Worldwide)

1,994

Industries

Pharmaceuticals

Company Description

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

Executives & Employees

Co-Chief Executive Officer

President, Chief Executive Officer & Director

Vice President & Head-Research

Auditor

Managing Director

Managing Director-Sales

Director & Managing Director

Board of Directors

Chairman & Chief Executive Officer at Green Cross Holdings Corp.

President, Chief Executive Officer & Director at Green Cross Corp.

Professor at Korea University

Managing Director at A-Jin Industrial Co., Ltd.

Managing Director-Sales at Green Cross Corp.

Director & Managing Director at Green Cross Corp.

Paths to Green Cross Corp.
Potential Connections via
Relationship Science
You
Green Cross Corp.
Owners & Shareholders
Details Hidden

PCP manages emerging markets equity portfolios by using different methods of analysis such as fundamental analysis; technical analysis; cyclical analysis; quantitative analysis; and qualitative analysis. They have a sector-specific investment approach where they define the common ground in emerging markets as the industrial sector and continuously screen the entire emerging market universe.

Details Hidden

PCP manages emerging markets equity portfolios by using different methods of analysis such as fundamental analysis; technical analysis; cyclical analysis; quantitative analysis; and qualitative analysis. They have a sector-specific investment approach where they define the common ground in emerging markets as the industrial sector and continuously screen the entire emerging market universe.

Recent Transactions
Details Hidden

Grifols SA purchases Green Cross Corp. /Plasma Assets from Green Cross Corp.

Details Hidden

Green Cross Corp. purchases UBCare Co., Ltd. from Kakao Investment Co. Ltd.

Details Hidden

Green Cross Corp., Green Cross Holdings Corp. purchase Ildong Holdings Co., Ltd. from Yeonhap Glass Co., Ltd.

Clients

The federal government of Canada is the body responsible for the federal administration of Canada. In Canadian English, the term can mean either the collective set of institutions (the legislative, executive, and judicial branches) or specifically the Queen-in-Council (the executive, also called Her Majesty's Government.

Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

The United Nations (UN) is an intergovernmental organization established on 24 October 1945 to promote international co-operation. A replacement for the ineffective League of Nations, the organization was created following the Second World War to prevent another such conflict. At its founding, the UN had 51 member states; there are now 193. The UN Headquarters resides in international territory in New York City, with further main offices in Geneva, Nairobi, and Vienna. The organization is financed by assessed and voluntary contributions from its member states. Its objectives include maintaining international peace and security, promoting human rights, fostering social and economic development, protecting the environment, and providing humanitarian aid in cases of famine, natural disaster, and armed conflict.

Key Stats and Financials As of 2020
Market Capitalization
$4.46B
Total Enterprise Value
$1.78B
Earnings Per Share
$6.61
Three Year Compounded Annual Growth Rate Of Revenue
5.31%
Revenue
$1.3B
Net Profit
$77.2M
Total Equity
$967M
Investments
Details Hidden

Amicogen, Inc. engages in the development and sale of enzyme products and functional food materials. Its products include specialty enzyme for pharmaceutical, food, feed, and industrial; new bio-ingredients such as natural health ingredients for food, feed and cosmetics; and immunological products such as protein A resin. The company was founded on May 29, 2000 and is headquartered in Jinju-si, South Korea.

Details Hidden

Argos Therapeutics, Inc. is a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and is headquartered in Durham, NC.

Details Hidden

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. It offers comprehensive contract research organization and contract manufacturing organization services. Its products include Euvichol, oral cholera vaccine, enteric infection vaccine, and anti-cancer vaccine. The company was founded on March 10, 2010 and is headquartered in Seoul, South Korea.

Suppliers
BioCryst Pharmaceuticals, Inc. Medical Support Services | Birmingham, Alabama

Founded in 1986, BioCryst has approximately 38 employees between the Company’s headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development and regulatory affairs, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. The commitment of BioCryst has remained unchanged. We continue to be passionate about advancing novel therapeutics for patients with serious diseases.

MacroGenics, Inc. Industrial Machinery & Manufacturing | Rockville, MD

MacroGenics is a leader in the discovery and development of innovative medicinces that utilize our next generation antibody-based technologies. Our team of 150+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer and other serious, complex diseases. Our products and platforms have attracted multiple partnerships with leading pharmaceutical companies around the globe. Our innovative product candidates leverage our fully-integrated capabilities around the discovery, development, and production of antibodies and incorporate three proprietary technology platforms: Our Dual-Affinity Re-Targeting (DART™) platform enables us to design candidate therapeutics that target multiple disease-causing cells or redundant disease-associated pathways with a single molecule; Our Fc Optimization platform enhances the natural immune system's ability to mediate killing of cancer cells; and Our Cancer Stem Cell platform provides new approaches to target cancers unresponsive to current therapy.

Bristol-Myers Squibb Company Medical Support Services | New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Competitors
Government of India Government - New Delhi, India

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Green Cross Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Green Cross Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Green Cross Corp..